The Gates Foundation will invest up to $50 million to support Tessera's SCD gene editing treatment, the company said.
Columnist Oluwatosin Adesoye shares a list of things that everyone should know and understand about sickle cell disease.
More than 500,000 babies were tested for sickle cell disease in Catalonia’s newborn screening program, with 160 cases ...
The European Commission has granted orphan medicinal product status to mitapivat, Agios Pharmaceuticals’ oral investigational therapy for sickle cell disease (SCD). This designation is granted to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback